Moderna CEO Stephane Bancel said Wednesday he expects the FDA to issue emergency use approval of its COVID vaccine for kids ages 12-to-17 in a few weeks.
Moderna CEO Stephane Bancel said Wednesday he expects the FDA to issue emergency use approval of its COVID vaccine for kids ages 12-to-17 in a few weeks.
Moderna's COVID-19 vaccine was found to be effective in adolescents aged 12-17 and showed no new or major safety problems in a..